(Brussels, Belgium) – – – Kidney Disease: Improving Global Outcomes (KDIGO) is pleased to announce the publication of its latest Controversies Conference Report in the European Heart Journal. It covers the KDIGO Conference on CKD & Arrhythmias held in Berlin, Germany in October 2016.
This meeting is part of a series of Controversies Conferences held by KDIGO on the relationship between chronic kidney disease and cardiovascular disease. It was co-chaired by Christoph Wanner of Germany, and Mintu Turakhia of the US. Dr. Wanner is a nephrologist at University Hospital of Würzburg, and Dr. Turakhia is a cardiologist at Stanford University. The participants in the conference were approximately 50% cardiologists and 50% nephrologists.
The conference was organized around five major issues in the topic. They were: Epidemiology of Atrial Fibrillation and Stroke in CKD; Stroke Prevention in Atrial Fibrillation and CKD; Potassium Homeostasis and Handling in CKD and Dialysis; Prevention of Sudden Cardiac Death in CKD; and Rate vs. Rhythm Control in CKD Patients with Atrial Fibrillation. There were more than 80 globally recognized experts in attendance who worked over two and a half days to arrive at relevant observations.
“We are very pleased to see this important paper published in a globally respected cardiology journal. The paper also will likely be complemented by an Executive Summary in Kidney International. This series is of critical importance to improving outcomes for the patients we share with our cardiology colleagues. Cardiovascular risk is always a factor in our treatment decisions at every stage of kidney disease. This conference, and the others in the series, will help clinicians make more informed decisions.”
– Wolfgang Winkelmayer, KDIGO Co-Chair
Wolfgang Winkelmayer, KDIGO Co-Chair said, “We are very pleased to see this important paper published in a globally respected cardiology journal. The paper also will likely be complemented by an Executive Summary in Kidney International. This series is of critical importance to improving outcomes for the patients we share with our cardiology colleagues. Cardiovascular risk is always a factor in our treatment decisions at every stage of kidney disease. This conference, and the others in the series, will help clinicians make more informed decisions.”
“KDIGO translates global science into practical observations that can guide doctors and patients as they seek to avoid serious cardiovascular events and threats. The conference series also stimulates greater collaboration between our two specialties,” Dr. Winkelmayer added.
KDIGO followed this conference with one on Heart Failure in CKD held in May 2017 in Athens, Greece, and another on Coronary Artery and Valvular Diseases that will be held in Vienna, Austria in June this year. The fourth conference in the series will be on Peripheral Artery Disease and Stroke in 2019.
KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve patient outcomes on a global basis.
For further information please contact KDIGO at [email protected].
# # #
